BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21850367)

  • 1. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
    Tozawa K; Sagawa M; Kizaki M
    Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    PLoS One; 2014; 9(4):e95846. PubMed ID: 24755677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
    Sha M; Ye J; Zhang LX; Luan ZY; Chen YB; Huang JX
    Pharmacology; 2014; 93(1-2):39-46. PubMed ID: 24434352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
    Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
    Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
    Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
    Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
    Yu X; Meng X; Xu M; Zhang X; Zhang Y; Ding G; Huang S; Zhang A; Jia Z
    EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells.
    Wu D; Zhang W; Chen Y; Ma H; Wang M
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1194-1200. PubMed ID: 31347196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
    Yang M; Huang J; Pan HZ; Jin J
    Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
    Wang Y; Zhang XL; Sun CM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
    Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P
    Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity.
    Zhong YL; Xu GJ; Huang S; Zhao L; Zeng Y; Xiao XF; An JL; Liu J; Yang T
    Eur J Pharmacol; 2019 Jun; 853():184-192. PubMed ID: 30928629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway.
    Yang L; Chen J; Han X; Zhang E; Huang X; Guo X; Chen Q; Wu W; Zheng G; He D; Zhao Y; Yang Y; He J; Cai Z
    Protein Cell; 2018 Sep; 9(9):770-784. PubMed ID: 29441489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of celastrol on enhancing apoptosis of ovarian cancer cells via the downregulation of microRNA‑21 and the suppression of the PI3K/Akt‑NF‑κB signaling pathway in an in vitro model of ovarian carcinoma.
    Zhang H; Li J; Li G; Wang S
    Mol Med Rep; 2016 Dec; 14(6):5363-5368. PubMed ID: 27840916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma.
    He D; Xu Q; Yan M; Zhang P; Zhou X; Zhang Z; Duan W; Zhong L; Ye D; Chen W
    BMC Cancer; 2009 Sep; 9():343. PubMed ID: 19778460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
    Du HF; Yu LJ; Meng YF; Lv HY; Meng J; Song XN; Zhang JQ
    Leuk Lymphoma; 2013 Mar; 54(3):607-18. PubMed ID: 22889356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway.
    Song IS; Jeong YJ; Nyamaa B; Jeong SH; Kim HK; Kim N; Ko KS; Rhee BD; Han J
    BMB Rep; 2015 Oct; 48(10):571-6. PubMed ID: 25772758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.